Small hepatocellular carcinoma with low tumor marker expression benefits more from anatomical resection than tumors with aggressive biology
Annals of Surgery Feb 13, 2019
Jung JH, et al. - The prognostic advantage of anatomical resection (AR) over nonanatomical resection (NAR) for hepatocellular carcinoma (HCC) was investigated according to the multiplication of α-fetoprotein, des-γ-carboxyprothrombin, and tumor volume (ADV) scores. Analyzing 1572 patients who underwent curative resection for solitary HCC of 2.0 to 5.0 cm between 2006 and 2014, they identified that AR in patients with ADV score ≤4 log or absence of microvascular invasion was prognostically beneficial. Compared to NAR, AR appears more beneficial for patients with less aggressive tumor biology, thus AR was reasonably indicated in these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries